Genworth Financial, Inc. (NYSE:GNW – Get Free Report) saw a significant growth in short interest in the month of September. As of September 15th, there was short interest totalling 5,690,000 shares, a growth of 5.2% from the August 31st total of 5,410,000 shares. Based on an average daily volume of 2,760,000 shares, the short-interest ratio is currently 2.1 days. Currently, 1.3% of the shares of the company are sold short.
Genworth Financial Trading Down 0.9 %
NYSE:GNW traded down $0.06 on Tuesday, hitting $6.79. The stock had a trading volume of 3,166,606 shares, compared to its average volume of 2,808,044. The company has a quick ratio of 0.29, a current ratio of 0.29 and a debt-to-equity ratio of 0.17. The stock has a market cap of $2.97 billion, a price-to-earnings ratio of 35.79 and a beta of 0.94. The company has a fifty day moving average price of $6.70 and a two-hundred day moving average price of $6.40. Genworth Financial has a 1-year low of $5.32 and a 1-year high of $7.01.
Genworth Financial (NYSE:GNW – Get Free Report) last issued its quarterly earnings data on Wednesday, July 31st. The financial services provider reported $0.28 EPS for the quarter, topping the consensus estimate of $0.19 by $0.09. Genworth Financial had a net margin of 0.43% and a return on equity of 0.25%. The firm had revenue of $1.77 billion for the quarter. During the same quarter in the prior year, the company posted $0.29 earnings per share.
Insider Activity at Genworth Financial
Hedge Funds Weigh In On Genworth Financial
Large investors have recently made changes to their positions in the stock. First Trust Direct Indexing L.P. increased its position in shares of Genworth Financial by 9.9% in the 1st quarter. First Trust Direct Indexing L.P. now owns 19,670 shares of the financial services provider’s stock valued at $126,000 after purchasing an additional 1,780 shares during the last quarter. Covestor Ltd increased its position in shares of Genworth Financial by 11.5% in the 1st quarter. Covestor Ltd now owns 18,131 shares of the financial services provider’s stock valued at $117,000 after purchasing an additional 1,868 shares during the last quarter. Sage Rhino Capital LLC increased its position in shares of Genworth Financial by 9.8% in the 2nd quarter. Sage Rhino Capital LLC now owns 21,899 shares of the financial services provider’s stock valued at $132,000 after purchasing an additional 1,950 shares during the last quarter. Nomura Asset Management Co. Ltd. grew its position in shares of Genworth Financial by 29.9% in the 4th quarter. Nomura Asset Management Co. Ltd. now owns 8,700 shares of the financial services provider’s stock valued at $58,000 after buying an additional 2,000 shares during the last quarter. Finally, EverSource Wealth Advisors LLC grew its position in shares of Genworth Financial by 72.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 4,828 shares of the financial services provider’s stock valued at $29,000 after buying an additional 2,022 shares during the last quarter. 81.85% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Separately, StockNews.com lowered shares of Genworth Financial from a “buy” rating to a “hold” rating in a report on Friday, September 6th.
Check Out Our Latest Report on Genworth Financial
Genworth Financial Company Profile
Genworth Financial, Inc, together with its subsidiaries, provides mortgage and long-term care insurance products in the United States and internationally. It operates in three segments: Enact, Long-Term Care Insurance, and Life and Annuities. The Enact segment offers private mortgage insurance products primarily insuring prime-based, individually underwritten residential mortgage loans; and pool mortgage insurance products.
Read More
- Five stocks we like better than Genworth Financial
- ETF Screener: Uses and Step-by-Step Guide
- Why Lennar Stock Could Be the Best Play in the Housing Market
- How Investors Can Find the Best Cheap Dividend Stocks
- 2 Energy Stocks Fueling the AI Datacenter Boom
- How to Most Effectively Use the MarketBeat Earnings Screener
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Genworth Financial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genworth Financial and related companies with MarketBeat.com's FREE daily email newsletter.